We are live on ! Find out more
AI

Accredited Investors Portfolio holdings

AUM $2.31B
1-Year Est. Return 33.7%
This Fund
S&P 500
This Quarter Est. Return
+2.46%
1 Year Est. Return
+33.7%
3 Year Est. Return
+74.04%
5 Year Est. Return
+69.22%
10 Year Est. Return
+269.29%
AUM
$1.4B
AUM Growth
+$85.6M
Cap. Flow
+$55.8M
Cap. Flow %
3.98%
Top 10 Hldgs %
55.68%
Holding
200
New
11
Increased
63
Reduced
80
Closed
10

Sector Composition

Rank Sector Weight
1 Industrials 11.4%
2 Technology 5.52%
3 Communication Services 4.43%
4 Financials 2.14%
5 Consumer Discretionary 1.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VV icon
126
Vanguard Morningstar Large-Cap ETF
VV
$54.5B
$365K 0.03%
1,800
NFLX icon
127
Netflix
NFLX
$309B
$365K 0.03%
8,280
HTGC icon
128
Hercules Capital
HTGC
$3.23B
$355K 0.03%
24,000
-1,000
-4% -$13.7K
IDV icon
129
iShares International Select Dividend ETF
IDV
$8.57B
$355K 0.03%
13,480
IVW icon
130
iShares S&P 500 Growth ETF
IVW
$77.6B
$350K 0.03%
4,969
-344
-6% -$22.7K
DG icon
131
Dollar General
DG
$27.9B
$347K 0.02%
2,042
ISRG icon
132
Intuitive Surgical
ISRG
$134B
$343K 0.02%
1,003
RTX icon
133
RTX Corp
RTX
$301B
$335K 0.02%
3,421
-594
-15% -$58.2K
VWO icon
134
Vanguard FTSE Emerging Markets ETF
VWO
$126B
$334K 0.02%
8,213
-1,015
-11% -$40.9K
OTTR icon
135
Otter Tail
OTTR
$3.94B
$331K 0.02%
4,195
+24
+0.6% +$1.8K
AMT icon
136
American Tower
AMT
$80.4B
$328K 0.02%
1,691
+301
+22% +$58.8K
AMGN icon
137
Amgen
AMGN
$222B
$326K 0.02%
1,469
-74
-5% -$17.2K
RVNC
138
DELISTED
Revance Therapeutics, Inc.
RVNC
$325K 0.02%
12,845
-7,646
-37% -$238K
APH icon
139
Amphenol
APH
$209B
$324K 0.02%
7,630
-370
-5% -$14.4K
VBR icon
140
Vanguard Morningstar Small-Cap Value ETF
VBR
$38.1B
$321K 0.02%
1,943
CELC icon
141
Celcuity
CELC
$4.52B
$320K 0.02%
29,115
F icon
142
Ford
F
$55.7B
$314K 0.02%
20,756
-384
-2% -$4.86K
PYPL icon
143
PayPal
PYPL
$50.5B
$306K 0.02%
4,590
-72
-2% -$4.91K
ECL icon
144
Ecolab
ECL
$79.9B
$302K 0.02%
1,616
-122
-7% -$21K
NEE icon
145
NextEra Energy
NEE
$177B
$300K 0.02%
4,046
KBWB icon
146
Invesco KBW Bank ETF
KBWB
$6.73B
$297K 0.02%
7,246
-15,533
-68% -$632K
TECH icon
147
Bio-Techne
TECH
$11.3B
$297K 0.02%
+3,642
New +$293K
IYW icon
148
iShares US Technology ETF
IYW
$25.5B
$295K 0.02%
2,706
+2
+0.1% +$196
GEHC icon
149
GE HealthCare
GEHC
$32.4B
$292K 0.02%
3,590
-1
-0% -$80
VEEV icon
150
Veeva Systems
VEEV
$37.4B
$291K 0.02%
+1,473
New +$269K

Similar funds

Accredited Investors's Q2 2023 Portfolio in Review

As of Q2 2023, Accredited Investors held 200 positions worth $1.4B, up 6.5% from $1.32B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

Accredited Investors deployed $55.8M of net new capital in Q2 2023, opening 11 new positions and adding to 63 existing holdings. Its largest new stake was Travelers Companies: 8,226 shares worth $1.43M.

By sector, the portfolio is most concentrated in Industrials at 11% of assets, down from 13% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was iShares MSCI EAFE Value ETF, an estimated $11.4M trimmed.

  • Accredited Investors's largest Q2 2023 buy was Travelers Companies: 8,226 shares worth $1.43M.
  • Accredited Investors added most to iShares 0-1 Year Treasury Bond ETF in Q2 2023, an estimated $45.2M increase.
  • Accredited Investors's biggest Q2 2023 reduction was iShares MSCI EAFE Value ETF, cutting an estimated $11.4M.
  • Accredited Investors fully exited Eli Lilly in Q2 2023, selling an estimated $1.03M.
  • Accredited Investors's ten largest holdings make up 56% of its $1.4B portfolio in Q2 2023.
  • Accredited Investors opened 11 new positions and closed 10 in Q2 2023.
  • Accredited Investors's portfolio value rose 6.5% quarter-over-quarter to $1.4B.

Based on Accredited Investors's 13F filing for Q2 2023, filed 3 Aug 2023.